276 related articles for article (PubMed ID: 25318062)
1. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.
Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R
Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062
[TBL] [Abstract][Full Text] [Related]
2. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.
Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R
Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080
[TBL] [Abstract][Full Text] [Related]
3. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
[TBL] [Abstract][Full Text] [Related]
4. MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
Liu J; Chen SJ; Hsu SW; Zhang J; Li JM; Yang DC; Gu S; Pinkerton KE; Chen CH
Theranostics; 2021; 11(9):4122-4136. PubMed ID: 33754052
[No Abstract] [Full Text] [Related]
5. Regulation of a Coupled MARCKS-PI3K Lipid Kinase Circuit by Calmodulin: Single-Molecule Analysis of a Membrane-Bound Signaling Module.
Ziemba BP; Swisher GH; Masson G; Burke JE; Williams RL; Falke JJ
Biochemistry; 2016 Nov; 55(46):6395-6405. PubMed ID: 27933776
[TBL] [Abstract][Full Text] [Related]
6. Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation.
Yu D; Makkar G; Strickland DK; Blanpied TA; Stumpo DJ; Blackshear PJ; Sarkar R; Monahan TS
J Am Heart Assoc; 2015 Oct; 4(10):e002255. PubMed ID: 26450120
[TBL] [Abstract][Full Text] [Related]
7. Myristoylation-dependent and electrostatic interactions exert independent effects on the membrane association of the myristoylated alanine-rich protein kinase C substrate protein in intact cells.
Swierczynski SL; Blackshear PJ
J Biol Chem; 1996 Sep; 271(38):23424-30. PubMed ID: 8798548
[TBL] [Abstract][Full Text] [Related]
8. Functional involvement of protein kinase C-betaII and its substrate, myristoylated alanine-rich C-kinase substrate (MARCKS), in insulin-stimulated glucose transport in L6 rat skeletal muscle cells.
Chappell DS; Patel NA; Jiang K; Li P; Watson JE; Byers DM; Cooper DR
Diabetologia; 2009 May; 52(5):901-11. PubMed ID: 19252893
[TBL] [Abstract][Full Text] [Related]
9. Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment.
Chen CH; Cheng CT; Yuan Y; Zhai J; Arif M; Fong LW; Wu R; Ann DK
Oncotarget; 2015 Jun; 6(17):15194-208. PubMed ID: 26015406
[TBL] [Abstract][Full Text] [Related]
10. Myristoylated alanine-rich C kinase substrate-mediated neurotensin release via protein kinase C-delta downstream of the Rho/ROK pathway.
Li J; O'Connor KL; Greeley GH; Blackshear PJ; Townsend CM; Evers BM
J Biol Chem; 2005 Mar; 280(9):8351-7. PubMed ID: 15623535
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein.
Ott LE; Sung EJ; Melvin AT; Sheats MK; Haugh JM; Adler KB; Jones SL
PLoS One; 2013; 8(6):e66512. PubMed ID: 23840497
[TBL] [Abstract][Full Text] [Related]
12. Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway.
Ziemba BP; Burke JE; Masson G; Williams RL; Falke JJ
Biophys J; 2016 Apr; 110(8):1811-1825. PubMed ID: 27119641
[TBL] [Abstract][Full Text] [Related]
13. Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.
Yang Y; Chen Y; Saha MN; Chen J; Evans K; Qiu L; Reece D; Chen GA; Chang H
Leukemia; 2015 Mar; 29(3):715-26. PubMed ID: 25179733
[TBL] [Abstract][Full Text] [Related]
14. Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.
Yang DC; Li JM; Xu J; Oldham J; Phan SH; Last JA; Wu R; Chen CH
FASEB J; 2019 Dec; 33(12):14354-14369. PubMed ID: 31661644
[TBL] [Abstract][Full Text] [Related]
15. Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate.
Fujise A; Mizuno K; Ueda Y; Osada S; Hirai S; Takayanagi A; Shimizu N; Owada MK; Nakajima H; Ohno S
J Biol Chem; 1994 Dec; 269(50):31642-8. PubMed ID: 7989336
[TBL] [Abstract][Full Text] [Related]
16. Binding of myristoylated alanine-rich protein kinase C substrate to phosphoinositides attenuates the phosphorylation by protein kinase C.
Seki K; Sheu FS; Huang KP
Arch Biochem Biophys; 1996 Feb; 326(2):193-201. PubMed ID: 8611023
[TBL] [Abstract][Full Text] [Related]
17. Membrane association of the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Mutational analysis provides evidence for complex interactions.
Swierczynski SL; Blackshear PJ
J Biol Chem; 1995 Jun; 270(22):13436-45. PubMed ID: 7768946
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.
Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH
Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200
[TBL] [Abstract][Full Text] [Related]
19. A PKC-MARCKS-PI3K regulatory module links Ca2+ and PIP3 signals at the leading edge of polarized macrophages.
Ziemba BP; Falke JJ
PLoS One; 2018; 13(5):e0196678. PubMed ID: 29715315
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival.
Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H
Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
